CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2

Area of Science:

• Biotechnology
• Molecular Biology
• Infectious Disease Diagnostics

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, highlighted the need for rapid diagnostic methods.
• Conventional reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 detection is costly, requires specialized equipment and personnel, and involves sample transport delays.
• These limitations impact timely diagnosis and treatment of COVID-19 patients.

Purpose of the Study:

• To review recent advances in CRISPR-based biosensing technologies for SARS-CoV-2 detection.
• To explore the potential applications of CRISPR-based approaches as alternatives to RT-PCR.
• To provide insights into the development of efficient and accurate COVID-19 diagnostic tools.

Main Methods:

• Review of current scientific literature on CRISPR-based biosensing for SARS-CoV-2.
• Analysis of the characteristics of CRISPR-based detection methods, including speed, sensitivity, specificity, and isothermal conditions.
• Comparison of CRISPR-based approaches with conventional RT-PCR methods.

Main Results:

• CRISPR-based approaches demonstrate visual, rapid, ultrasensitive, and specific detection of SARS-CoV-2.
• These methods operate effectively under isothermal conditions, simplifying the detection process.
• CRISPR technology shows potential for point-of-care diagnostics, reducing reliance on centralized laboratories.

Conclusions:

• CRISPR-based biosensing technologies are emerging as powerful tools for SARS-CoV-2 detection.
• They offer significant advantages over RT-PCR, including speed, cost-effectiveness, and ease of use.
• CRISPR presents a viable and attractive alternative for efficient and accurate COVID-19 diagnosis and surveillance.